TP53 and neoplasm: Interestingly, the activation of the IFN-β response seemed to be dependent on cell–cell contact, since CM derived from mutant p53-harboring cells and CAFs caused increased activation of this response, while CM derived from tumor cells alone produced a much milder effect.